MENU
SNPHF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Santen Pharmaceutical (SNPHF) Ownership - Who owns Santen Pharmaceutical?
Profile
Industry
N/A
Address
Grand Front Osaka Tower A
Phone
+81 663217000
Employees
4073
Web
http://www.santen.co.jp
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
3.26B
P/E Ratio
15.31
Total Cash
62.32B
Projected Growth
N/A
Total Debt
40.09B
Revenue
270.24B
Risk (Beta)
0.32
Dividend Yield
0.03
Total Cash/Share
168.46
Total Debt/Equity
N/A
Revenue/Share
5.12 USD as % of share price
Fundamentals
SNPHF
Capitalization
3.26B
P/E Ratio
15.31
Risk (Beta)
0.32
Dividend Yield
0.03
Total Cash
62.3B
Total Cash/Share
168.46
Total Debt
40.1B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.12%
Revenue
270B
ROE
N/A
Book Value
301B
P/B Ratio
1.51
Cash Flow
N/A
Earnings
-21.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.68B
Current Ratio
2.73
Current Revenue Per Employee
16424334.00
Dividends Per Share - Security
0.00
EBITDA
17.2B
Float
N/A
Float - Current
N/A
Gross Income Margin
58.31
Revenue To Assets
-1.93
Shares Held By Institutions
43.4B
Shares Outstanding - Current
370M
Total Liabilities
120B
Total Volume MTD
N/A
Value
1
Gain YTD
5.573
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsMajor
Profile
Fundamentals
Details
Industry
N/A
Address
Grand Front Osaka Tower A
Phone
+81 663217000
Employees
4073
Web
http://www.santen.co.jp